 The purpose of this study is to assess the relative bioavailability the extent to which a drug or other substance becomes available to the body of simeprevir SMV following single dose administration of age-appropriate oral formulation candidates compared to the 150 milligram mg capsule, and to assess the effect of food on the bioavailability of SMV following single dose administration of a selected age-appropriate oral formulation candidate. 